Nomination Committee appointed for Bactiguard Holding AB’s Annual General Meeting 2025
The Nomination Committee for the Annual General Meeting of Bactiguard Holding AB (publ), to be held on Thursday 15 May…
3,215€
2,06%
Echtzeit-Aktienkurs Bactiguard Holding AB
Bid:
Ask:
Nachrichten zur Bactiguard Holding AB Aktie
Global Airway Management Tubes And Intubation Accessories Devices Market Size To Worth USD 3.3 Billion by 2033 | CAGR Of 6.25%
The Global Airway Management Tubes And Intubation Accessories Devices Market Size was valued at USD 1.8 Billion in 2023 and…
Bactiguard Holding AB’s interim report second quarter 2024
License revenues and EBITDA stabilizing
Second quarter 2024 (April – June)
· Total revenue amounted to SEK 60.9 (51.2) million,…
Bulletin from Bactiguard Holding AB’s (publ) Annual General Meeting
At Bactiguard Holding AB’s (publ) Annual General Meeting (AGM) on 14 May 2024, the following resolutions were made:
The AGM adopted…
Christine Lind assumes role as CEO of Bactiguard Holding AB as of today
The Board of Bactiguard Holding AB (publ.) today announces that Christine Lind will assume the role as CEO per 12…
Notice to attend the Annual General Meeting of Bactiguard Holding AB
The shareholders of Bactiguard Holding AB (publ), company reg. no. 556822-1187 (“Bactiguard”), are hereby given notice to attend the Annual…
Bactiguard Holding AB’s Annual and Sustainability Report 2023
The Annual and Sustainably Report 2023 for Bactiguard Holding AB (publ) is now available at www.bactiguard.com
Bactiguard underwent a major transformation…
Bactiguard publishes updated financial targets in alignment with sharpened license focused strategy
Following the announcement of Bactiguard’s sharpened license focused strategy on October 5, 2023, the company today publishes its updated financial…
Invitation to presentation of Bactiguard’s interim report for the third quarter 2023
Bactiguard Holding AB (publ) publishes its interim report for the third quarter on Friday October 27, 2023 at 08:00 CEST.
In…
Bactiguard strengthens licensing with Anders Göransson entering new role as Global Head of Licensing. Thomas von Koch appointed interim CEO
The Board of Bactiguard Holding AB (publ) (“Bactiguard”) today announces that current CEO Anders Göransson will step down as CEO…
Clinical study launched to compare efficacy of Bactiguard coated central venous catheters with non-coated
To gain additional clinical evidence of the efficacy of central venous catheters with Bactiguards infection prevention coating technology (BIP CVC),…
ZNN Bactiguard trauma nails get regulatory approvals in Japan
Since entering the initial license partnership with Zimmer Biomet, the ZNN Bactiguard trauma implants have been successfully launched across Europe,…
Dr. Richard Kuntz suggested new board member of Bactiguard Holding AB
Bactiguard Holding AB (publ) today announces the Nomination Committees proposal of Dr. Richard (Rick) Kuntz as new board member. Rick…
Notice to attend the Annual General Meeting of Bactiguard Holding AB
The shareholders of Bactiguard Holding AB (publ), company reg. no. 556822-1187 (“Bactiguard”), are hereby given notice to attend the Annual…
Bactiguard launches Wound Care line in the UK and Ireland
Bactiguard offers a broad range of infection prevention solutions, from a unique coating technology to a portfolio of coated medical…
Bactiguard receives first MDR product approval
STOCKHOLM, Jan. 10, 2023 /PRNewswire/ -- Bactiguard today announces its first MDR (Medical Device Regulations 2017/745) product approval following a…
Bactiguard receives first MDR product approval
Bactiguard today announces its first MDR (Medical Device Regulations 2017/745) product approval following a comprehensive authorization process. The MDR approval…